New York Late Money Rates from The Wall Street Journal
Dow Jones2026/10/29 21:49Key annual interest rates paid to borrow or lend money in U.S. and international markets. Rates below are a guide to general levels but don’t always represent actual transactions.
Thursday, October 29, 2026 Inflation Sept. index Chg From (%) level Aug. '26 Sept. '25 U.S. consumer price index All items 336.940 0.59 3.7 Core 339.287 0.37 2.6 International rates Week 52-Week Latest ago High Low Prime rates U.S. 7.00 7.00 7.00 6.75 Canada 4.45 4.45 4.70 4.45 Japan 2.38 2.38 2.38 1.88
Policy Rates Euro zone 2.65 2.65 2.65 2.15 Switzerland 0.25 0.25 0.50 0.25 Britain 3.75 3.75 4.00 3.75 Australia 4.60 4.60 4.60 3.60 Overnight repurchase U.S. 3.98 3.93 4.18 3.49 U.S. government rates Discount 4.00 4.00 4.00 3.75 Federal funds Target rate 3.75-4.00 3.75-4.00 3.75-4.00 3.50-3.75 High 3.95 3.95 3.95 3.70 Low 3.80 3.80 3.85 3.55 Bid 3.88 3.88 3.88 3.61 Offer 3.89 3.89 3.89 3.63 Treasury bill auction 4 weeks 3.910 3.945 4.000 3.550 13 weeks 4.050 4.095 4.110 3.540 26 weeks 4.210 4.220 4.285 3.475 Other short-term rates Week 52-Week Latest ago High Low Call money 5.75 5.75 5.75 5.50 Commercial paper (AA financial) 90 days 4.08 n.a. 4.16 3.57 Secured Overnight Financing Rate (SOFR) 3.94 3.88 4.27 3.50 Value 52-Week Latest Traded High Low DTCC GCF Repo Index Treasury 3.967 54.300 4.288 3.504 MBS 3.979 130.332 4.304 3.517
Weekly survey Latest Week ago Year ago Freddie Mac 30-year fixed 7.24 7.32 6.17 15-year fixed 6.60 6.68 5.41
Notes on data: U.S. prime rate is the base rate on corporate loans posted by at least 70% of the 10 largest U.S. banks, and is effective September 17, 2026. Other prime rates aren’t directly comparable; lending practices vary widely by location; Discount rate is effective September 17, 2026. Secured Overnight Financing Rate is as of October 28, 2026. DTCC GCF Repo Index is Depository Trust & Clearing Corp.'s weighted average for overnight trades in applicable CUSIPs. Value traded is in billions of U.S. dollars.
Sources: Federal Reserve; Bureau of Labor Statistics; DTCC; FactSet; Tullett Prebon Information, Ltd.
(END) Dow Jones Newswires
October 29, 2026 17:49 ET (21:49 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Rocket Lab’s stock falls as quarterly loss exceeds expectations
BUZZ-Take-Two shares rise after raising annual revenue and profit forecasts
Itaúsa Q3 2026 recurring net profit rises 25% to R$ 5.06 billion year-on-year
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.